Literature DB >> 16088828

Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.

Andreas Sandgren1, Barbara Albiger, Carlos J Orihuela, Elaine Tuomanen, Staffan Normark, Birgitta Henriques-Normark.   

Abstract

Streptococcus pneumoniae isolates of serotypes 1, 4, 6B, 7F, 14, and 19F belonging to clonal types with known invasive disease potential in humans were used to infect C57BL/6 and BALB/c mice. Most isolates were able to colonize the nasopharynx for 7 days. One serotype 19F isolate of the clonal type ST162 had higher bacterial numbers than other isolates and clonal types of the same serotype. Serotype 4 clones caused the most-severe invasive disease, whereas serotype 1 clones caused low-level bacteremia without disease symptoms. BALB/c mice were more likely than C57BL/6 mice to develop meningitis. Disease kinetics varied significantly between clonal types. Although most induced a robust tumor necrosis factor response, some isolates of serotype 1 and 7F did not, suggesting that invasive disease caused by different clonal types may result in different degrees of host response. Capsular serotype, other clonal properties, and host factors are important for the development of pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088828     DOI: 10.1086/432513

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates.

Authors:  Nuno A Silva; Jackie McCluskey; Johanna M C Jefferies; Jason Hinds; Andrew Smith; Stuart C Clarke; Tim J Mitchell; Gavin K Paterson
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 2.  The pneumococcus: epidemiology, microbiology, and pathogenesis.

Authors:  Birgitta Henriques-Normark; Elaine I Tuomanen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

3.  Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.

Authors:  L E Cron; K Stol; P Burghout; S van Selm; E R Simonetti; H J Bootsma; P W M Hermans
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

4.  The histone demethylase KDM6B fine-tunes the host response to Streptococcus pneumoniae.

Authors:  Michael G Connor; Tiphaine M N Camarasa; Emma Patey; Orhan Rasid; Laura Barrio; Caroline M Weight; Daniel P Miller; Robert S Heyderman; Richard J Lamont; Jost Enninga; Melanie A Hamon
Journal:  Nat Microbiol       Date:  2020-12-21       Impact factor: 17.745

Review 5.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.

Authors:  Catherine Hyams; Jose Yuste; Katie Bax; Emilie Camberlein; Jeffrey N Weiser; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

7.  Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

Authors:  J M Jefferies; A J Smith; G F S Edwards; J McMenamin; T J Mitchell; S C Clarke
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

8.  Site of isolation determines biofilm formation and virulence phenotypes of Streptococcus pneumoniae serotype 3 clinical isolates.

Authors:  Claudia Trappetti; Erika van der Maten; Zarina Amin; Adam J Potter; Austen Y Chen; Paula M van Mourik; Andrew J Lawrence; Adrienne W Paton; James C Paton
Journal:  Infect Immun       Date:  2012-12-03       Impact factor: 3.441

9.  A pneumococcal pilus influences virulence and host inflammatory responses.

Authors:  M A Barocchi; J Ries; X Zogaj; C Hemsley; B Albiger; A Kanth; S Dahlberg; J Fernebro; M Moschioni; V Masignani; K Hultenby; A R Taddei; K Beiter; F Wartha; A von Euler; A Covacci; D W Holden; S Normark; R Rappuoli; B Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-15       Impact factor: 11.205

10.  Discovery of novel inhibitors of Streptococcus pneumoniae based on the virtual screening with the homology-modeled structure of histidine kinase (VicK).

Authors:  Nan Li; Fei Wang; Siqiang Niu; Ju Cao; Kaifeng Wu; Youqiang Li; Nanlin Yin; Xuemei Zhang; Weiliang Zhu; Yibing Yin
Journal:  BMC Microbiol       Date:  2009-06-27       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.